Maintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study

被引：0

作者：

Thomas, M. ^{[1
]}

Ponce Aix, S. ^{[2
]}

Navarro Mendivil, A. ^{[3
]}

Riera Knorrenschild, J. ^{[4
]}

Schmidt, M. ^{[5
]}

Wiegert, E. ^{[6
]}

Kapp, K. ^{[7
]}

Mauri, C. ^{[8
]}

Domine Gomez, M. ^{[9
]}

Kollmeier, J. ^{[10
]}

Sadjadian, P. ^{[11
]}

Froehling, K-P. ^{[12
]}

Huber, R. M. ^{[13
]}

Wolf, M. ^{[14
]}

机构：

[1] Heidelberg Univ Hosp, Thorac Oncol, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC H,Thoraxkli, Heidelberg, Germany

[2] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain

[3] Vall dHebron Univ Hosp, Vall dHebron Inst Res VHIR, Barcelona, Spain

[4] Uniklinikum Giessen & Marburg, Klin Hamatol Onkol & Immunol, Marburg, Germany

[5] Mologen AG, Early & Translat R&D, Berlin, Germany

[6] Mologen AG, Clin Dev, Berlin, Germany

[7] Mologen AG, Translat R&D, Berlin, Germany

[8] UCL, Div Med, London, England

[9] Fdn Jimenez Diaz, Dept Med Oncol, Univ Hosp, Madrid, Spain

[10] Helios Klinikum Emil von Behring GmbH, Lungenklin Heckeshorn, Berlin, Germany

[11] Johannes Weseling Klinikum, Klin Hamatol Onkol & Palliat Med, Minden, Germany

[12] Kath Klinikum Koblenz Montabaur, Klin Innere Med Pneumol, Koblenz, Germany

[13] Univ Munich, LMU Klinikum, Thorac Oncol Ctr Munich, Munich, Germany

[14] Klin Kassel, Med Klin 4, Kassel, Germany

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1672P

引用

页码：599 / 599

页数：1

共 50 条

[31] The Impact of the Stage III Randomized Trial by Takahashi et al. on the Use of Prophylactic Cranial Irradiation (PCI) in Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
Gjyshi, O.
Ludmir, E. B.
Dursteler, A.
Lin, S. H.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 230 - 230
[32] Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol
Deng, Lei
Shayan, Gulidanna
Jiang, Wei
Bi, Nan
Wang, Luhua
THORACIC CANCER, 2024, 15 (11) : 938 - 943
[33] Consolidative and salvage thoracic radiotherapy (TRT) in extensive-stage small-cell lung cancer (ES-SCLC) with first-line chemoimmunotherapy: a retrospective study from a single cancer center
Lan, Aihua
Dong, Huiling
Zheng, Zhiqin
Chu, Xiao
Zhu, Zhengfei
LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
[34] A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)
Socinski, M
Weissman, C
Hart, L
Beck, J
Choksi, J
Hanson, J
Prager, D
Bloss, L
Ze, Y
Obasaju, C
LUNG CANCER, 2005, 49 : S328 - S329
[35] A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC).
Socinski, MA
Weissman, CH
Hart, LL
Beck, JT
Choksi, JK
Hanson, JP
Prager, D
Bloss, LP
Ye, Z
Obasaju, CK
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 661S - 661S
[36] Tifcemalimab combined with toripalimab and chemotherapy as 1st line treatment for extensive-stage small cell lung cancer (ES-SCLC): A phase Ib/II, open-label study
Yu, Yongfeng
Yu, Yan
Zhang, Yan
Zhang, Wei
Lv, Dongqing
Chen, Yuan
Huang, Dingzhi
Zhang, Mingjun
Li, Yongsheng
Li, Dairong
Gao, Junzhen
Wu, Lin
He, Zhiyong
Shi, Jianhua
Zhao, Mingfang
Liu, Anwen
Wang, Chunyue
Zhu, Hui
Lu, Shun
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[37] A phase II trial of carboplatin and irinotecan as first-line therapy for extensive stage small cell lung cancer (ES-SCLC): Preliminary results
Laskin, J
Shirley, B
Dobbs, T
Bi, J
Carbone, D
Johnson, D
Sandler, A
LUNG CANCER, 2005, 49 : S323 - S323
[38] Results from a randomized study of carboplatin and etoposide (CE) with or without palifosfamide (Pa) in extensive stage small cell lung cancer (ES-SCLC): The MATISSE study.
Jalal, Shadia Ibrahim
Einhorn, Lawrence H.
Lo, Gregory
Lavin, Philip
Lebel, Francois M.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[39] Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
Spigel, David R.
Townley, Peter M.
Waterhouse, David M.
Fang, Liang
Adiguzel, Ibrahim
Huang, Jane E.
Karlin, David A.
Faoro, Leonardo
Scappaticci, Frank A.
Socinski, Mark A.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2215 - 2222
[40] Burden of Chemotherapy-induced Myelosuppression on Patients with Extensive-stage Small Cell Lung Cancer (ES-SCLC) from the Perspective of Patients and Caregivers
Abraham, Ivo
Zincavage, Rebekah
Ito, Diane
Padilla, Brad
Sussman, Matthew
Moore, Michelle
Huang, Huan
Crawford, Jeffrey
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E18 - E18

← 1 2 3 4 5 →